Correction: Lai et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling (Cancers, (2021), 13(5), (940), 10.3390/cancers13050940)

The authors wish to make the following corrections to this paper [1]: In the original article, there were mistakes in Figure 6 due to our data storage system encountering an unknown hardware error. Some image files were accidentally duplicated into other, inappropriate folders. We previously sent the wrong (old) version of the manuscript with incorrect images in Figure 6B (panel 10), 6C (panel 1) and 6D (panel 2) because the paper was undergoing a process of multiple revisions at the time of the data storage system error occurring. Now we want to correct these mistakes. However, these changes do not impact the scientific value of the article. The corrected Figure 6 appears below.Figure 6. Increased susceptibility of LmiR21 zebrafish to diethylnitrosamine (DEN)-induced liver fibrosis and carcinogenesis. (A) Experimental design of three independent DEN treatments and doxycycline (Dox) dosing. (B) Representative images of livers with microscopic tumors identified following hematoxylin & eosin staining (indicated with arrows) one, three, and nine months after DEN treatment. Scale bar: 100 µm. (C) Representative images of livers with microscopic injuries identified by Masson’s trichome staining at one, three, and nine months after DEN treatment. Scale bar: 50 µm. (D) Representative images of livers with microscopic injuries identified by Sirius red staining at one, three, and nine months after DEN treatment. Scale bar: 50 µm. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.